Parkinson’s UK commit further funding to develop drugs that protect mitochondria
We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Understanding coronavirus and Parkinson’s
We’ve all seen coronavirus (or COVID-19) in the headlines. Our priority remains supporting people living with Parkinson’s. That’s why we’ve gathered the facts and guidance to help answer some of your most common questions about coronavirus and Parkinson’s.
Help researchers adapt their studies
Researchers are taking steps to invite people back to take part in face-to-face studies. To help them make sure their research resumes in a safe, practical, and convenient way, we'd like you to take part in a survey.
Mental health staffing recruitment targets missed
Government missed target on recruiting mental health staff. This could impact on people with Parkinson’s
New report calls for changes in neurological mental health care
A new report released today (24 July) shows that people with neurological conditions, such as Parkinson’s, struggle to access effective mental health care that meets their needs.
Raising your concerns about social care
An update on meetings we’ve had this week about social care that raise the concerns of our community.
How have coronavirus (COVID-19) restrictions impacted people affected by Parkinson’s?
With Lancaster University, we conducted a survey that shows the coronavirus restrictions are having a big impact on the lives and the health of people affected by Parkinson’s.
Protecting the future of research after coronavirus (COVID-19)
Medical research charities have come together and are asking the government to act now and set up a fund to ensure that the future of charity-funded research is protected
Loneliness and life after lockdown
How loneliness is affecting people during the pandemic and some ways to tackle it
Replacing cells lost in Parkinson’s
New one-step process converts cells inside the brain into dopamine-producing cells to replace those lost in Parkinson's.